Metanew-R 25 Tablet SR
Marketer
Genexwell Biotech
Salt Composition
Metoprolol Succinate (25mg) + Ramipril (2.5mg)
Overview Metanew-R 25 Tablet SR
CardioReduce 25mg Extended-Release tablets manage hypertension, reducing the risk of stroke and heart attack. Early use improves heart attack survival rates. Take CardioReduce 25mg ER with food daily at the same time for consistent blood levels; continue as directed, even if feeling well, as hypertension is often asymptomatic. Discontinuing may worsen your condition. Lifestyle changes – exercise, weight management, and a healthy diet – also aid blood pressure control. Follow your physician's instructions. Potential side effects include nausea, dry cough, headache, fatigue, hypotension, and hyperkalemia. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly. Regular monitoring of blood pressure, blood glucose, kidney function, urea, and electrolytes may be necessary. Inform your doctor of any liver or kidney issues, or pregnancy/breastfeeding, before starting. Always disclose all medications, especially those for hypertension or heart conditions.
Primary Ingredients of Metanew-R 25 Tablet SR
The provided text is "undefined," therefore no rewriting is possible.
Uses of Metanew-R 25 Tablet SR
Elevated arterial blood pressure
Major Benefits of Metanew-R 25 Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Metanew-R 25 Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.
Common Side effects of Metanew-R 25 Tablet SR:
- Nausea
- Taste change
- Vomiting
- Diarrhea
- Constipation
- Cough
- Dizziness
- Weakness
- Headache
- Cold extremities
- Slow heart rate
- Numbness of extremity
- Increased potassium level in blood
- Decreased blood pressure
How to use Metanew-R 25 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Metanew-R 25 SR Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Take with food.
How Metanew-R 25 Tablet SR works:
The extended-release Metanew-R 25 tablet combines metoprolol and ramipril to effectively manage hypertension. Metoprolol, a beta-blocker, decreases heart rate and improves cardiac output. Ramipril, an ACE inhibitor, lessens cardiac strain and promotes vasodilation for improved blood flow.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metanew-R 25 Tablet SR and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Metanew-R 25 Tablet SR during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in potentially life-threatening circumstances where the physician deems the benefits outweigh the hazards. Medical advice is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metanew-R 25mg tablets are likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Metanew-R 25mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with impaired kidney function should use Metanew-R 25 Tablet SR cautiously, as dose modification may be necessary. Physician consultation is advised. Routine blood pressure checks are recommended to guide dosage alterations.
LiverCAUTION
Patients with liver impairment should use Metanew-R 25 Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. Report any jaundice symptoms immediately to your doctor during treatment.
What if you forget to take Metanew-R 25 Tablet SR :
Should you forget a Metanew-R 25 Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metanew-R 25 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Heart |



